Navigation Links
Ethnicity Key Factor in Determining Cardiovascular Risk Profile

BEIJING, June 17 /PRNewswire-Asia/ -- Racial-ethnic groups living in a similar environment and with access to universal healthcare differed strikingly in their cardiovascular risk profiles according to new data presented today at the World Congress of Cardiology (WCC) Scientific Sessions in Beijing, China.

Chinese people have the most favorable cardiovascular risk profile, followed by White, South Asians and then Blacks according to the study presented. Moreover, diabetes occurred earlier in South Asian men and women, and Black women than in people of White or Chinese origin. A similar racial-ethnic gradient was observed in the prevalence of heart disease (3.2 per cent in Chinese to a high of 5.2 per cent in South Asians) and stroke (0.6 per cent in Chinese to a high of 1.7 per cent in South Asians).

"Cardiovascular disease is a global health problem and even though Chinese, South Asians and Blacks represent approximately 60 per cent of the world's population and contribute significantly to the global burden of this disease, most of our knowledge about cardiovascular risk is derived from White populations," said Maria Chiu, Doctoral Research Fellow, Institute for Clinical Evaluation Sciences, Toronto, Canada. "The data generated by our study will be invaluable for designing evidence-based prevention programs and for planning health services in an increasingly multi-ethnic world."

The population-based study compared cardiovascular risk factors and diseases of some 163,797 participants (154,653 White, 3,038 Chinese, 3,364 South Asian, 2,742 Black) in Statistics Canada's National Population Health Survey and Canadian Community Health Surveys between 1996 and 2007. Direct age-sex standardized methods were used to estimate ethnic-specific prevalence of eight cardiovascular risk factors, heart disease and stroke.

About the World Congress of Cardiology

The World Congress of Cardiology Scientific Sessions is the official congress of the World Heart Federation and is held every two years. Through the Congress the World Heart Federation offers an international stage for the latest developments in science and public outreach in the field of cardiovascular health. The World Congress of Cardiology places emphasis on the complementary nature of science and public outreach and strives to spread the message that through individual, community and patient-care interventions, the growing epidemic of cardiovascular diseases can be prevented.

About the World Heart Federation

The World Heart Federation is dedicated to leading the global fight against heart disease and stroke with a focus on low- and middle-income countries via a united community of more than 200 member organizations. With its members, the World Heart Federation works to build global commitment to addressing cardiovascular health at the policy level, generates and exchanges ideas, shares best practice, advances scientific knowledge and promotes knowledge transfer to tackle cardiovascular disease - the world's number one killer. It is a growing membership organization that brings together the strength of medical societies and heart foundations from more than 100 countries. Through our collective efforts we can help people all over the world to lead longer and better heart-healthy lives. For more information, please visit

SOURCE World Heart Federation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Groundbreaking Ceremony in Port-au-Prince, Haiti for FilterPure Water Filtration Factory
2. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
3. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
4. deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
5. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
6. ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)
7. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
8. deCODE Discovers Four New Risk Factors for Prostate Cancer
9. Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones
10. Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis
11. QualTech Laboratories Validates USP Protocols for Anti-Factor IIa Chromogenic Assay for Potency
Post Your Comments:
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... , Nov. 25, 2015 Research and ... the "Membranes Market - Global Forecast to 2020" ... Asia-Pacific , accounting for 37.21% of the total ... Asia-Pacific region is projected to growth ... growth has been attributed primarily to the fast growing ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials ... the Narconon network, announced the release of a new cutting edge recovery program that ... has been working with drug- and alcohol-addicted individuals with the purpose to free addicts ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Smiles by ... TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the ... the great success Botox® delivers to those suffering with discomfort, soreness, and pain as ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... MA (PRWEB) , ... November 25, 2015 , ... Many ... — fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who ... their diet and exercise regimen instead of their thyroid, especially if they don’t have ...
Breaking Medicine News(10 mins):